Overview

Efficacy Study to Evaluate the Effectiveness of 3 Concentrations of SAR 1118 in Allergic Conjunctivitis

Status:
Completed
Trial end date:
2009-05-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether SAR 1118 at three different concentrations, compared to placebo, is effective in the prevention of the signs and symptoms of allergic conjunctivitis
Phase:
Phase 2
Details
Lead Sponsor:
Shire
Treatments:
Lifitegrast
Ophthalmic Solutions